Core Laboratories N.V.
NYSE:CLB
17.07 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 509.79 | 489.735 | 470.252 | 487.267 | 668.21 | 700.846 | 659.809 | 594.741 | 797.52 | 1,085.222 | 1,073.508 | 981.08 | 907.648 | 794.653 | 695.539 | 780.836 | 670.54 | 575.689 | 483.467 | 427.427 | 405.637 | 364.748 | 376.572 | 336.098 | 303.7 | 286.2 | 214.9 | 105.4 | 80.1 |
| Cost of Revenue
| 415.741 | 410.816 | 386.412 | 395.634 | 518.184 | 520.051 | 499.18 | 469.516 | 560.109 | 691.967 | 688.439 | 644.736 | 593.369 | 513.79 | 457.769 | 514.782 | 449.191 | 407.099 | 368.123 | 336.392 | 326.921 | 301.308 | 293.308 | 268.655 | 245.4 | 220.5 | 170.5 | 84.7 | 64.2 |
| Gross Profit
| 94.049 | 78.919 | 83.84 | 91.633 | 150.026 | 180.795 | 160.629 | 125.225 | 237.411 | 393.255 | 385.069 | 336.344 | 314.279 | 280.863 | 237.77 | 266.054 | 221.349 | 168.59 | 115.344 | 91.035 | 78.716 | 63.44 | 83.264 | 67.443 | 58.3 | 65.7 | 44.4 | 20.7 | 15.9 |
| Gross Profit Ratio
| 0.184 | 0.161 | 0.178 | 0.188 | 0.225 | 0.258 | 0.243 | 0.211 | 0.298 | 0.362 | 0.359 | 0.343 | 0.346 | 0.353 | 0.342 | 0.341 | 0.33 | 0.293 | 0.239 | 0.213 | 0.194 | 0.174 | 0.221 | 0.201 | 0.192 | 0.23 | 0.207 | 0.196 | 0.199 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 40.259 | 38.117 | 44.173 | 34.033 | 48.023 | 62.91 | 47.737 | 39.39 | 49.729 | 45.655 | 51.988 | 43.185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -1.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 38.894 | 38.117 | 44.173 | 34.033 | 48.023 | 62.91 | 47.737 | 39.39 | 49.729 | 45.655 | 51.988 | 43.185 | 41.141 | 33.029 | 30.372 | 31.646 | 33.837 | 33.082 | 37.846 | 28.14 | 22.787 | 20.183 | 15.929 | 13.54 | 12.3 | 8.4 | 6 | 3.6 | 2.7 |
| Other Expenses
| 0.515 | -0.722 | 5.595 | -1.826 | -5.319 | 0.737 | -0.452 | 0.344 | -3.669 | -1.069 | 0.338 | 4.121 | 22.384 | 20.908 | 20.616 | 28.543 | 3.664 | 11.951 | 16.567 | 16.381 | 22.61 | 22.499 | 27.783 | 19.218 | 18.7 | 16.5 | 11 | 4.6 | 3.1 |
| Operating Expenses
| 39.409 | 37.395 | 44.173 | 34.033 | 48.023 | 62.91 | 47.737 | 39.39 | 49.729 | 45.655 | 51.988 | 43.185 | 63.525 | 53.937 | 50.988 | 60.189 | 37.501 | 45.033 | 54.413 | 44.521 | 45.397 | 42.682 | 43.712 | 32.758 | 31 | 24.9 | 17 | 8.2 | 5.8 |
| Operating Income
| 54.64 | 41.524 | 45.262 | 55.774 | 96.684 | 118.622 | 112.44 | 86.179 | 161.07 | 346.531 | 333.419 | 297.28 | 250.754 | 226.926 | 186.782 | 206.713 | 183.848 | 123.557 | 60.931 | 46.514 | 33.319 | 20.758 | 36.577 | 34.685 | 27.3 | 40.8 | 27.4 | 12.5 | 10.1 |
| Operating Income Ratio
| 0.107 | 0.085 | 0.096 | 0.114 | 0.145 | 0.169 | 0.17 | 0.145 | 0.202 | 0.319 | 0.311 | 0.303 | 0.276 | 0.286 | 0.269 | 0.265 | 0.274 | 0.215 | 0.126 | 0.109 | 0.082 | 0.057 | 0.097 | 0.103 | 0.09 | 0.143 | 0.128 | 0.119 | 0.126 |
| Total Other Income Expenses Net
| -13.43 | -11.57 | -9.152 | -14.372 | -14.69 | -13.328 | -8.262 | -11.572 | -12.38 | -10.6 | -9.317 | -8.82 | -11.912 | -17.778 | -15.523 | 1.55 | -2.551 | -5.805 | -14.289 | -8.275 | -5.07 | -5.382 | -7.921 | -8.314 | -8.558 | -3.921 | -2.6 | -1.3 | -2.8 |
| Income Before Tax
| 41.21 | 29.954 | 36.11 | -91.177 | 81.994 | 105.294 | 101.706 | 74.607 | 148.69 | 335.931 | 324.102 | 288.46 | 238.842 | 209.148 | 171.259 | 208.605 | 181.297 | 117.752 | 46.642 | 38.239 | 25.617 | 13.155 | 28.656 | 27.36 | 5.1 | 33.7 | 22 | 11.4 | 7.3 |
| Income Before Tax Ratio
| 0.081 | 0.061 | 0.077 | -0.187 | 0.123 | 0.15 | 0.154 | 0.125 | 0.186 | 0.31 | 0.302 | 0.294 | 0.263 | 0.263 | 0.246 | 0.267 | 0.27 | 0.205 | 0.096 | 0.089 | 0.063 | 0.036 | 0.076 | 0.081 | 0.017 | 0.118 | 0.102 | 0.108 | 0.091 |
| Income Tax Expense
| 4.185 | 10.296 | 15.891 | 5.896 | -12.29 | 25.447 | 18.61 | 10.748 | 33.758 | 77.305 | 80.908 | 71.848 | 54.198 | 63.747 | 57.164 | 65.002 | 60.192 | 35.09 | 14.925 | 10.217 | 6.917 | 5.525 | 8.024 | 8.208 | 1.7 | 10.1 | 6.6 | 3.7 | 2.2 |
| Net Income
| 36.675 | 19.453 | 19.727 | -97.073 | 101.983 | 79.526 | 83.125 | 63.895 | 114.847 | 257.485 | 242.811 | 216.071 | 184.684 | 144.917 | 113.604 | 143.603 | 121.105 | 82.662 | 31.211 | 12.29 | 18.7 | -9.062 | 20.632 | 19.152 | 3.4 | 20 | 15.4 | 7.7 | 4.2 |
| Net Income Ratio
| 0.072 | 0.04 | 0.042 | -0.199 | 0.153 | 0.113 | 0.126 | 0.107 | 0.144 | 0.237 | 0.226 | 0.22 | 0.203 | 0.182 | 0.163 | 0.184 | 0.181 | 0.144 | 0.065 | 0.029 | 0.046 | -0.025 | 0.055 | 0.057 | 0.011 | 0.07 | 0.072 | 0.073 | 0.052 |
| EPS
| 0.79 | 0.42 | 0.51 | -2.18 | 2.11 | 1.8 | 1.88 | 1.45 | 2.71 | 5.9 | 5.38 | 4.66 | 3.99 | 3.23 | 2.47 | 2.85 | 2.58 | 1.65 | 0.6 | 0.23 | 0.31 | -0.14 | 0.31 | 0.28 | 0.035 | 0.3 | 0.31 | 0.18 | 0.11 |
| EPS Diluted
| 0.77 | 0.42 | 0.5 | -2.16 | 2.1 | 1.79 | 1.88 | 1.45 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3 | 2.43 | 2.74 | 2.48 | 1.54 | 0.56 | 0.22 | 0.3 | -0.14 | 0.3 | 0.27 | 0.035 | 0.29 | 0.3 | 0.17 | 0.11 |
| EBITDA
| 70.424 | 58.685 | 63.778 | -56.502 | 119.289 | 141.709 | 134.492 | 114.323 | 188.527 | 373.227 | 358.89 | 316.543 | 271.471 | 247.724 | 210.6 | 231.657 | 203.324 | 141.25 | 77.992 | 63.656 | 56.158 | 40.523 | 62.087 | 53.751 | 39.161 | 57.012 | 41.7 | 17.1 | 13.2 |
| EBITDA Ratio
| 0.138 | 0.12 | 0.136 | 0.157 | 0.179 | 0.202 | 0.208 | 0.145 | 0.231 | 0.319 | 0.311 | 0.303 | 0.302 | 0.315 | 0.304 | 0.293 | 0.28 | 0.236 | 0.174 | 0.148 | 0.138 | 0.119 | 0.187 | 0.158 | 0.199 | 0.203 | 0.174 | 0.16 | 0.164 |